Profil
Carl Bjartmar worked as a Senior Medical Director at Sanofi Aventis AB and Genzyme AB.
He then served as the Chief Medical Officer at Wilson Therapeutics AB from 2015 to 2018 and at Ascelia Pharma AB from 2018 to 2022.
He holds a doctorate degree from the University of Linköping.
Anciens postes connus de Carl Bjartmar
| Sociétés | Poste | Fin |
|---|---|---|
| ASCELIA PHARMA AB | Directeur Technique/Scientifique/R&D | 31/12/2022 |
| WILSON THERAPEUTICS AB | Directeur Technique/Scientifique/R&D | 01/09/2018 |
Genzyme AB
 Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Directeur Technique/Scientifique/R&D | - |
Sanofi Aventis AB
 Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | Directeur Technique/Scientifique/R&D | - |
Formation de Carl Bjartmar
| University of Linköping | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Sanofi Aventis AB
Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | |
Genzyme AB
Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |